Singular Genomics Systems Inc expected to post a loss of 43 cents a share - Earnings Preview

Singular Genomics Systems

28/02/2023 21:35

* Singular Genomics Systems Inc  OMIC.OQ   OMIC.O  is
expected
to show a rise in quarterly revenue when it reports  results on
March 2. 
    * The San Diego California-based  company is expected to
report
revenue of $759.8 thousand, according to the mean estimate from
5 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Singular Genomics
Systems
Inc is for a loss of 43 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $2.5​, above​ its last closing price of $2.09.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.41       -0.41      -0.33     Beat    20.3
 Jun. 30 2022  -0.39       -0.38      -0.34     Beat    11.5
 Mar. 31 2022  -0.33       -0.33      -0.31     Beat    7​
 Dec. 31 2021  -0.31       -0.31      -0.27     Beat    12.3
 ​​Sep.        -0.24       -0.24      -0.25     Missed  -4.2
 30 2021                                                
 Jun. 30 2021  -0.20       -0.20      -0.43     Missed  -111.5
                                                        ​
 This summary was machine generated February 28 at 21:35 GMT. 
All figures in US dollars  unless otherwise stated